Fatty Acid Supplementation Reverses the Small Colony Variant Phenotype in Triclosan-Adapted Staphylococcus aureus: Genetic, Proteomic and Phenotypic Analyses

Scientific Reports
Abdulrahman S BazaidAndrew J McBain

Abstract

Staphylococcus aureus can develop a small colony variant (SCV) phenotype in response to sub-lethal exposure to the biocide triclosan. In the current study, whole genome sequencing was performed and changes in virulence were investigated in five Staphylococcus aureus strains following repeated exposure to triclosan. Following exposure, 4/5 formed SCV and exhibited point mutations in the triclosan target gene fabI with 2/4 SCVs showing mutations in both fabI and fabD. The SCV phenotype was in all cases immediately reversed by nutritional supplementation with fatty acids or by repeated growth in the absence of triclosan, although fabI mutations persisted in 3/4 reverted SCVs. Virulence, determined using keratinocyte invasion and Galleria mellonella pathogenicity assays was significantly (p < 0.05) attenuated in 3/4 SCVs and in the non-SCV triclosan-adapted bacterium. Proteomic analysis revealed elevated FabI in 2/3 SCV and down-regulation in a protein associated with virulence in 1/3 SCV. In summary, attenuated keratinocyte invasion and larval virulence in triclosan-induced SCVs was associated with decreases in growth rate and virulence factor expression. Mutation occurred in fabI, which encodes the main triclosan target in all SC...Continue Reading

References

Aug 26, 1998·Nature·L M McMurryS B Levy
May 23, 2001·Archives of Biochemistry and Biophysics·J VillalaínV Micol
Oct 21, 2005·Journal of Bacteriology·Maria M SennBrigitte Berger-Bächi
Nov 25, 2005·Letters in Applied Microbiology·M Gomez EscaladaD Ochs
Mar 17, 2006·Nature Reviews. Microbiology·Richard A ProctorGeorg Peters
Jun 3, 2008·Applied and Environmental Microbiology·Louise E MooreAndrew J McBain
Apr 21, 2009·Nature Methods·Jacek R WiśniewskiMatthias Mann
Aug 15, 2009·Nature Reviews. Microbiology·Henry F Chambers, Frank R Deleo
Nov 26, 2009·Journal of Bacteriology·Markus MainieroChristiane Wolz
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Joe LatimerAndrew J McBain
Dec 29, 2012·Journal of Visualized Experiments : JoVE·Nalini RamaraoDidier Lereclus
Jun 1, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Barbara C Kahl
Aug 15, 2014·Frontiers in Cellular and Infection Microbiology·Richard A ProctorGeorg Peters
Dec 21, 2017·Frontiers in Microbiology·Jérôme JosseAlan Diot

❮ Previous
Next ❯

Citations

Sep 22, 2020·ACS Omega·Robel DemissieLeslie W-M Fung

❮ Previous
Next ❯

Software Mentioned

Progenesis LC - MS
Progenesis
ImageJ
MicrobesNG
Mascot
Prism

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.